Logo image of EXAI

EXSCIENTIA PLC (EXAI) Stock Price, Quote, News and Overview

NASDAQ:EXAI - Nasdaq - US30223G1022 - ADR - Currency: USD

4.84  +0.15 (+3.2%)

After market: 4.85 +0.01 (+0.21%)

EXAI Quote, Performance and Key Statistics

EXSCIENTIA PLC

NASDAQ:EXAI (11/19/2024, 8:18:05 PM)

After market: 4.85 +0.01 (+0.21%)

4.84

+0.15 (+3.2%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High7.91
52 Week Low3.8
Market Cap633.18M
Shares130.82M
Float95.77M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO10-01 2021-10-01


EXAI short term performance overview.The bars show the price performance of EXAI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

EXAI long term performance overview.The bars show the price performance of EXAI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of EXAI is 4.84 USD. In the past month the price decreased by -4.16%. In the past year, price decreased by -21.94%.

EXSCIENTIA PLC / EXAI Daily stock chart

EXAI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About EXAI

Company Profile

EXAI logo image Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company is headquartered in Oxford, Oxfordshire and currently employs 483 full-time employees. The company went IPO on 2021-10-01. The firm combines precision design with integrated experimentation to invent and develop drugs. The company uses artificial intelligence (AI) in drug discovery to progress AI-designed small molecules into a clinical setting. The company uses the patient's tissue data to define optimal profiles for research, improve experimental assessment during design and improve outcomes in a medical setting. The company has developed an internal pipeline focused on oncology, while its partnered pipeline extends to various other therapeutic areas. The company combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. The firm's experimental platform records responses in real patient samples allowing it to generate high-precision views of potential patient response. Its product pipeline consists of GTAEXS617, EXS4318, EXS74539, and EXS73565.

Company Info

EXSCIENTIA PLC

The Schrodinger Building, Oxford Science Park

Oxford OXFORDSHIRE GB

Employees: 483

Company Website: https://www.exscientia.ai/

Phone: 441865818941

EXSCIENTIA PLC / EXAI FAQ

What is the stock price of EXSCIENTIA PLC today?

The current stock price of EXAI is 4.84 USD. The price increased by 3.2% in the last trading session.


What is the ticker symbol for EXSCIENTIA PLC stock?

The exchange symbol of EXSCIENTIA PLC is EXAI and it is listed on the Nasdaq exchange.


On which exchange is EXAI stock listed?

EXAI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EXSCIENTIA PLC stock?

8 analysts have analysed EXAI and the average price target is 5.46 USD. This implies a price increase of 12.75% is expected in the next year compared to the current price of 4.84. Check the EXSCIENTIA PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EXSCIENTIA PLC worth?

EXSCIENTIA PLC (EXAI) has a market capitalization of 633.18M USD. This makes EXAI a Small Cap stock.


How many employees does EXSCIENTIA PLC have?

EXSCIENTIA PLC (EXAI) currently has 483 employees.


What are the support and resistance levels for EXSCIENTIA PLC (EXAI) stock?

EXSCIENTIA PLC (EXAI) has a support level at 4.64 and a resistance level at 5.45. Check the full technical report for a detailed analysis of EXAI support and resistance levels.


Is EXSCIENTIA PLC (EXAI) expected to grow?

The Revenue of EXSCIENTIA PLC (EXAI) is expected to grow by 63.9% in the next year. Check the estimates tab for more information on the EXAI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EXSCIENTIA PLC (EXAI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EXSCIENTIA PLC (EXAI) stock pay dividends?

EXAI does not pay a dividend.


What is the Price/Earnings (PE) ratio of EXSCIENTIA PLC (EXAI)?

EXSCIENTIA PLC (EXAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.65).


EXAI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to EXAI. When comparing the yearly performance of all stocks, EXAI is a bad performer in the overall market: 87.66% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EXAI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to EXAI. EXAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EXAI Financial Highlights

Over the last trailing twelve months EXAI reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS increased by 5.11% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -25.37%
ROE -36.43%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-24.14%
Sales Q2Q%46.6%
EPS 1Y (TTM)5.11%
Revenue 1Y (TTM)-19.64%

EXAI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 48% to EXAI. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 42.38% and a revenue growth 63.9% for EXAI


Ownership
Inst Owners20.13%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts47.5
Price Target5.46 (12.81%)
EPS Next Y42.38%
Revenue Next Year63.9%